如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)

在长期扩展研究 BREEZE-AD3 的随机子研究中,巴瑞替尼成功治疗中重度特应性皮炎患者后,与连续给药相比的减量或停药的疗效

return icon返回

Efficacy of downtitration or treatment withdrawal compared to continuous dosing, after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomised substudy from the long-term extension study, BREEZE-AD3

作者:Kristian Reich, Eric Simpson, Andreas Wollenberg, Robert Bissonnette, Masatoshi Abe, Tracy Cardillo, Jonathan Janes, Luna Sun, Sherry Chen, Jonathan I Silverberg
期刊:British Journal of Dermatology
发表日期:11/17/2022
卷/期/页码:Online ahead of print
相关文献材料(12)

通过扫描二维码

体验礼来医学网小程序

通过扫描二维码

体验礼来医学网Sina微博

mini iconsearch icon
return icon打开礼来医学网小程序